As regards the prognostic significance of the JAK2 haplotype GGCC_46/1 in AML cases, it was demonstrated that cases with a normal karyotype bearing the haplotype GGCC_46/1 showed a trend towards myelomonocytic proliferation and shorter disease-free survival and overall survival compared to GGCC_46/1 non carriers; on the other hand, the haplotype GGCC_46/1 had no impact on prognosis in the subgroup of AML with an abnormal karyotype [ 13 , 25 ].
← all excerpts
The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?
1
—
—